Applied DNA Sciences Inc Warrant
APDNW
APDNW was delisted on the 18th of November, 2019.
5 hedge funds and large institutions have $1K invested in Applied DNA Sciences Inc Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
99% less capital invested
Capital invested by funds: $91K → $1K (-$90K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$566 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$95 |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$86K |
APDNW Hedge Fund Activity: Q3 2019 in Review
5 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Applied DNA Sciences Inc Warrant (APDNW) for Q3 2019, worth a combined $1K — down 99% from $91K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of APDNW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $566. The largest seller was Sabby Management, exiting entirely with an estimated $86K sold.
- 5 institutional investors held Applied DNA Sciences Inc Warrant (APDNW) as of Q3 2019, down from 6 in Q2 2019.
- Funds reported $1K of Applied DNA Sciences Inc Warrant stock for Q3 2019, down 99% quarter-over-quarter.
- 0 funds opened new Applied DNA Sciences Inc Warrant positions in Q3 2019 and 1 closed out, a net change of -1 holder.
- The largest Applied DNA Sciences Inc Warrant buyer in Q3 2019 was Susquehanna International Group, an estimated $566 added.
- The largest Applied DNA Sciences Inc Warrant seller in Q3 2019 was Sabby Management, an estimated $86K sold.
Based on aggregated 13F filings for Q3 2019.